SAHaRA: A Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

742

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

July 10, 2024

Study Completion Date

August 22, 2024

Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
OTHER

Liberal RBC Transfusion Strategy

RBC transfusion is triggered by a Hemoglobin value of ≤100g/L

OTHER

Restrictive RBC Transfusion Strategy

Optional RBC transfusion is triggered by a Hemoglobin value of ≤80g/L

Trial Locations (23)

30322

Emory University School of Medicine, Atlanta

60612

Rush University Medical Center, Chicago

80045

University of Colorado School of Medicine, Aurora

Unknown

Nepean Hospital, Kingswood

Prince of Wales Hospital, Randwick

Royal North Shore Hospital, St Leonards

Royal Brisbane & Women's Hospital, Herston

The Alfred, Melbourne

Foothills Medical Center, Calgary

University of Alberta Hospital, Edmonton

Vancouver General Hospital, Vancouver

Royal Jubilee Hospital, Victoria

Winnipeg Health Sciences Center, Winnipeg

Nova Scotia Health Authority, Halifax

Hamilton Health Sciences Center, Hamilton

Kingston Health Sciences Centre, Kingston

London Health Sciences Center, London

Sunnybrook Research Institute, Toronto

Centre hospitalier de l'Université de Montréal, Montreal

Montreal Neurological Institute and Hospital, Montreal

Centre hospitalier universitaire de Québec-Université Laval, Québec

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

K1Y 4E9

Shane English, Ottawa

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Hospital Research Institute

OTHER

NCT03309579 - SAHaRA: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter